IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 445 to 456 of 456
7 October 2007

IDPC Advocacy Guide, Version 1

The first version of this guide has been posted on the IDPC website. It serves as an introduction to the structure and operation of the UN drug control system, and describes the forthcoming process of review leading to the political meeting in 2009.
1 August 2007

IDPC Briefing Paper Number 6 - The World Drug Report 2007

This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.
1 January 2007

IDPC 5 Policy Principles

This short paper summarises the five fundamental principles for effective drug policies that have been developed and agreed by IDPC members through research, analysis and debate over the last two years.
1 January 2006

IDPC Briefing Paper Number 1 - The UNGASS Evaluation Process Evaluated

At the 49th Session of the Commission on Narcotic Drugs (CND), held in Vienna in March 2006, a draft resolution was tabled by the European Union (EU) to guide the process of evaluation of the implementation of political declaration and action plans of the 1998 UN General Assembly Special Session (UNGASS) in 2008.
1 January 2005

IDPC Position Paper Number 1 - 2005 Commission on Narcotic Drugs

This position paper describes the concerns of some Consortium members at the apparent policy differences emerging between different United Nations agencies, and individual member states, in the run up to the annual meeting of the UN agency responsible for oversight of the global drug control system.